Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

ISR

IsoRay (ISR)

IsoRay Inc
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:ISR
DateHeureSourceTitreSymboleSociété
31/05/202422h05Edgar (US Regulatory)Form 8-K - Current reportAMEX:ISRIsoRay Inc
30/05/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ISRIsoRay Inc
24/05/202415h14Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:ISRIsoRay Inc
24/05/202413h06Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesAMEX:ISRIsoRay Inc
24/05/202413h00Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersAMEX:ISRIsoRay Inc
19/04/202422h05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsAMEX:ISRIsoRay Inc
18/04/202422h11Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:ISRIsoRay Inc
18/04/202422h09Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:ISRIsoRay Inc
10/04/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:ISRIsoRay Inc
09/04/202422h25Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:ISRIsoRay Inc
08/04/202422h12Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:ISRIsoRay Inc
01/04/202413h46Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:ISRIsoRay Inc
29/03/202412h35Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933AMEX:ISRIsoRay Inc
28/03/202413h34Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]AMEX:ISRIsoRay Inc
18/03/202421h18Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesAMEX:ISRIsoRay Inc
08/03/202417h22Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:ISRIsoRay Inc
06/02/202401h18Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:ISRIsoRay Inc
01/02/202413h56Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:ISRIsoRay Inc
01/02/202413h38Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipAMEX:ISRIsoRay Inc
17/01/202419h40Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]AMEX:ISRIsoRay Inc
14/11/202322h59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:ISRIsoRay Inc
14/06/202322h46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ISRIsoRay Inc
14/06/202322h42Edgar (US Regulatory)Specialized Disclosure Report (sd)AMEX:ISRIsoRay Inc
15/05/202323h23Edgar (US Regulatory)Quarterly Report (10-q)AMEX:ISRIsoRay Inc
15/05/202323h16Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ISRIsoRay Inc
01/05/202323h04Edgar (US Regulatory)Annual Transition Report (10-kt)AMEX:ISRIsoRay Inc
17/03/202322h09Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:ISRIsoRay Inc
08/03/202313h30GlobeNewswire Inc.Perspective Therapeutics Announces the Awarding of a $1 million Collaborative Grant to King’s College London to Support Radiobiology Research of Alpha Particle Therapy for CancerAMEX:ISRIsoRay Inc
22/02/202323h02GlobeNewswire Inc.Initial Results From First Patient Dosed With Perspective Therapeutics’ Lead Drug VMT-α-NET Presented at The Treatment of Neuroendocrine Disorders at the 2023 PET/RTRC Annual Workshop Scientific SessionAMEX:ISRIsoRay Inc
21/02/202312h02Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:ISRIsoRay Inc
 Showing the most relevant articles for your search:AMEX:ISR